Invest in the Future of Surgery
Our mission is to fundamentally change the nature of surgery and allow previously unimaginable surgical techniques in the most difficult-to-reach areas of the body. Join us to help bring the next generation of surgical technology to surgeons and patients around the world.
Class A Preferred Shares
7% paid-in-kind dividend
Upon a change of control, shares are redeemed with a bonus multiple of: • 100% after 1 year • 200% after 3 years • 300% after 5 years
$1.00 per share
We have applied to extend our Offering, and our extension of the Offering is being reviewed by the United States Securities and Exchange Commission. Until they approve our extension, we cannot accept additional investments. Unfortunately, we do not know how long the SEC’s process will take. If you have any questions or concerns, please email Mark Pickrell at firstname.lastname@example.org. We apologize for any inconvenience.
An offering statement regarding this offering has been filed with the SEC. The SEC has qualified the offering statement, which only means that the company may make sales of the securities described by the offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. Investors should read the offering circular before making any investment.